Alzamend Neuro's total assets for Q3 2025 were $4.18M, a decrease of -16.62% from the previous quarter. ALZN total liabilities were $725.85K for the fiscal quarter, a -42.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.